# ACPs Combined With CABG in Patients With CHF

> **NCT00523224** · PHASE1 · UNKNOWN · sponsor: **TheraVitae Ltd.** · enrollment: 5 (estimated)

## Conditions studied

- Congestive Heart Failure

## Interventions

- **PROCEDURE:** Angiogenic Cell Precursors(ACPs) or Vescell TM
- **BIOLOGICAL:** Angiogenic Cell Precusors

## Key facts

- **NCT ID:** NCT00523224
- **Lead sponsor:** TheraVitae Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-01
- **Primary completion:** —
- **Final completion:** 2007-09
- **Target enrollment:** 5 (ESTIMATED)
- **Last updated:** 2007-08-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00523224

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00523224, "ACPs Combined With CABG in Patients With CHF". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00523224. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*